ARTICLE | Clinical News
Biomatrix regulatory update
April 5, 1999 7:00 AM UTC
South Africa granted marketing approval for BXM's Synvisc modified natural hyaluronan to treat osteoarthritis of the knee. Partner F. Hoffmann-La Roche Ltd. (Basel, Switzerland) subsidiary Roche Pro...